Atlas Trials

An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

Clinical trial NCT01281306 · COMPLETED

Trial details

NCT number
NCT01281306
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Systolic Hypertension
Start date
2011-01-01
Primary completion
2011-12-01
Enrollment
910

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.